Although human studies have reported heterogeneous findings regarding the effects of CS on NLRP3 inflammasome activation, more recent evidence indicates that mitochondria-derived damage-associated molecular patterns (DAMPs) induced by CS can trigger NLRP3 activation, thereby exacerbating pulmonary inflammation and promoting atherosclerosis [3,4]. The gene discussed is NLRP3; the disease is atherosclerosis.